Ocuphire Pharma Price to Free Cash Flow Ratio 2010-2024 | IRD
Historical price to free cash flow ratio values for Ocuphire Pharma (IRD) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Ocuphire Pharma Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2024-10-24 |
1.13 |
|
0.00 |
| 2024-06-30 |
1.53 |
$-0.43 |
0.00 |
| 2024-03-31 |
2.01 |
$-0.11 |
0.00 |
| 2023-12-31 |
3.01 |
$-0.05 |
0.00 |
| 2023-09-30 |
3.35 |
$1.15 |
2.92 |
| 2023-06-30 |
4.34 |
$1.08 |
4.02 |
| 2023-03-31 |
3.75 |
$0.85 |
4.42 |
| 2022-12-31 |
3.53 |
$0.70 |
5.08 |
| 2022-09-30 |
2.01 |
$-1.21 |
0.00 |
| 2022-06-30 |
1.92 |
$-1.08 |
0.00 |
| 2022-03-31 |
3.24 |
$-1.11 |
0.00 |
| 2021-12-31 |
3.73 |
$-1.31 |
0.00 |
| 2021-09-30 |
5.15 |
$-1.93 |
0.00 |
| 2021-06-30 |
5.28 |
$-2.15 |
0.00 |
| 2021-03-31 |
5.81 |
$-2.10 |
0.00 |
| 2020-12-31 |
6.49 |
$-1.77 |
0.00 |
| 2020-09-30 |
8.32 |
$6.61 |
1.26 |
| 2020-06-30 |
11.36 |
$4.53 |
2.51 |
| 2020-03-31 |
7.20 |
$3.17 |
2.27 |
| 2019-12-31 |
7.64 |
$-1.27 |
0.00 |
| 2019-09-30 |
8.20 |
$-14.52 |
0.00 |
| 2019-06-30 |
20.64 |
$-18.51 |
0.00 |
| 2019-03-31 |
24.48 |
$-23.73 |
0.00 |
| 2018-12-31 |
44.64 |
$-27.57 |
0.00 |
| 2018-09-30 |
85.44 |
$-28.95 |
0.00 |
| 2018-06-30 |
67.68 |
$-28.32 |
0.00 |
| 2018-03-31 |
72.48 |
$-27.25 |
0.00 |
| 2017-12-31 |
96.96 |
$-27.16 |
0.00 |
| 2017-09-30 |
116.16 |
$-22.98 |
0.00 |
| 2017-06-30 |
137.28 |
$-23.89 |
0.00 |
| 2017-03-31 |
244.80 |
$-29.20 |
0.00 |
| 2016-12-31 |
68.11 |
$-29.23 |
0.00 |
| 2016-09-30 |
100.80 |
$-37.36 |
0.00 |
| 2016-06-30 |
120.58 |
$-42.69 |
0.00 |
| 2016-03-31 |
158.45 |
$-43.42 |
0.00 |
| 2015-12-31 |
174.24 |
$-45.85 |
0.00 |
| 2015-09-30 |
249.60 |
$-42.77 |
0.00 |
| 2015-06-30 |
291.70 |
$-37.82 |
0.00 |
| 2015-03-31 |
350.40 |
$-33.78 |
0.00 |
| 2014-12-31 |
336.00 |
$-30.22 |
0.00 |
| 2014-09-30 |
388.80 |
$-30.69 |
0.00 |
| 2014-06-30 |
417.60 |
$-28.67 |
0.00 |
| 2014-03-31 |
518.40 |
$-31.03 |
0.00 |
| 2013-12-31 |
244.80 |
$-29.99 |
0.00 |
| 2013-09-30 |
218.35 |
$-26.07 |
0.00 |
| 2013-06-30 |
213.12 |
$-29.40 |
0.00 |
| 2013-03-31 |
146.40 |
$-29.31 |
0.00 |
| 2012-12-31 |
148.80 |
$-32.72 |
0.00 |
| 2012-09-30 |
242.40 |
$-54.43 |
0.00 |
| 2012-06-30 |
153.60 |
$-62.07 |
0.00 |
| 2012-03-31 |
254.40 |
$-76.38 |
0.00 |
| 2011-12-31 |
180.48 |
$-80.23 |
0.00 |
| 2011-09-30 |
480.00 |
$-69.99 |
0.00 |
| 2011-06-30 |
595.20 |
$-61.18 |
0.00 |
| 2011-03-31 |
566.40 |
$-49.21 |
0.00 |
| 2010-12-31 |
537.60 |
$-42.68 |
0.00 |
| 2010-09-30 |
556.80 |
$-37.09 |
0.00 |
| 2010-06-30 |
686.40 |
$-39.75 |
0.00 |
| 2010-03-31 |
777.60 |
$-38.12 |
0.00 |
| 2009-12-31 |
326.40 |
$-40.37 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
|
|
$0.000B |
$0.000B |
|
Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.
|
